USANA Health Sciences net sales dropped 7% in fiscal 2019 according to its annual report. The future outlook is clouded even further by the expected continuing market dislocations caused by the coronavirus crisis in China.
The year 2019 was a solid one for the omega-3 business, with sales remaining steady. In the US, the market was mostly flat, but strong regional growth in the Asia-Pacific region and other emerging markets led to category growth overall.
Singaporeans are consuming an increasing amount of vitamins and supplements, with overall expenditure reaching US$374.4m (S$490m) last year — up US$5.5m from 2016— according to market research firm Euromonitor.
The global nutraceuticals market is expected to reach a value of $302,306m by the year 2022, on the back of CAGR of 7.04%. But, according to new research, APAC is poised to outstrip the global growth average.
China’s Premier Li Keqiang says Traditional Chinese medicine (TCM) manufacturers should look to develop mainstream dietary supplements using Western medical knowledge in order to boost export potential.
In the second part of our interview with DuPont’s Asia regional president Dr Li Yongjing, we assess the potential for the dietary supplements industry in South East Asia and examine why probiotics may be about to go mainstream in emerging markets.
Easy availability and a growing interest in fitness trends see about 78% of adolescents in urban India consume at least one type of dietary supplement, a survey by the Associated Chambers of Commerce and Industry (ASSOCHAM) said.